Matthew Gall

Finansdirektör/CFO på TANGO THERAPEUTICS, INC.

49 år

Health Technology

Consumer Services

Profil

Matthew Gall is currently Chief Financial Officer at Tango Therapeutics, Inc. since 2026.
Formerly, Mr. Gall was Chief Financial Officer & Treasurer at Kalaris Therapeutics, Inc. from 2025 to 2026, Chief Financial Officer at iTeos Therapeutics, Inc. from 2020 to 2025, and Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
Education includes an undergraduate degree from Bowling Green State University and an MBA from The University of Chicago Booth School of Business.

Aktiva positioner av Matthew Gall

Företag	Position	Start
TANGO THERAPEUTICS, INC.	Finansdirektör/CFO	2026-04-15

Alla aktiva positioner av Matthew Gall

Tidigare kända positioner av Matthew Gall

Företag	Position	Slut
ITEOS THERAPEUTICS, INC.	Finansdirektör/CFO	2025-08-28
SAREPTA THERAPEUTICS, INC.	Företagsledare/Principal	2020-06-01

Se detaljerna i Matthew Galls erfarenhet

Matthew Galls utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Matthew Galls erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy	Health Technology
Bowling Green State University Bowling Green State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Chicago Booth School of Business The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
iTeos Therapeutics, Inc. iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments	Health Technology
Tango Therapeutics, Inc. Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines	Health Technology